Literature DB >> 6286055

Neurofibrosarcoma at irradiation site in a patient with neurofibromatosis and Wilms' tumor.

J Y Chu, D M O'Connor, R K Danis.   

Abstract

A female patient with neurofibromatosis had nephrectomy performed because of Wilms' tumor at the age of four and a half. She received radiation therapy and chemotherapy (actinomycin D) after surgery. She had subsequent local recurrence and lung metastasis, which were surgically excised and successfully treated with additional radiation therapy and chemotherapy (vincristine and actinomycin D). However, neurofibrosarcoma at the irradiation site developed seven years after radiation therapy. She died 22 months later because of recurrence and metastasis of neurofibrosarcoma. Radiation therapy's association with malignant transformation of neurofibroma is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6286055     DOI: 10.3322/canjclin.31.6.333

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  3 in total

Review 1.  Radiation induced peripheral nerve tumors: case series and review of the literature.

Authors:  Gelareh Zadeh; Chris Buckle; Patrick Shannon; Eric M Massicotte; Shun Wong; Abhijit Guha
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

Review 2.  Breast cancer associated with neurofibromatosis type 1: a case series and review of the literature.

Authors:  Jihane Khalil; Mohamed Afif; Hanan Elkacemi; Meryem Benoulaid; Tayeb Kebdani; Noureddine Benjaafar
Journal:  J Med Case Rep       Date:  2015-03-19

3.  Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.

Authors:  Janna A Hol; Roland P Kuiper; Freerk van Dijk; Esmé Waanders; Sophie E van Peer; Marco J Koudijs; Reno Bladergroen; Simon V van Reijmersdal; Lionel M Morgado; Jet Bliek; Maria Paola Lombardi; Saskia Hopman; Jarno Drost; Ronald R de Krijger; Marry M van den Heuvel-Eibrink; Marjolijn C J Jongmans
Journal:  J Clin Oncol       Date:  2022-03-01       Impact factor: 50.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.